Aspirin Enteric Coated 75mg Tablets (Low Dose Aspirin)
Aspirin

Aspirin Enteric Coated 75mg Tablets (Low Dose Aspirin)

Aspirin Enteric Coated 75mg Tablets, commonly referred to as low dose aspirin is useful for patients suffering from angina and after a heart attack or stroke and following by-pass surgery. Not to be used for pain relief.


Size : 56 Tablets

Rating: Click to rate Click to rate Click to rate Click to rate Click to rate
140 customers rated this
write a review & win £50!

Code: 0009017  
Price: £69.00 & this item ships with FREE Delivery.
RRP: £4.58 You Save: £-64.42
Quantity:
Add to Basket
In Stock

Aspirin Enteric Coated Tablets belong to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It prevents blood cells, or platelets, from producing thromboxane. It is this substance that can cause platelets to clump together and start off the process of blood clotting. This can be dangerous, as it could cause a blockage that cuts off the blood supply to an organ. A blockage in the arteries supplying blood to the heart or brain can cause a heart attack or stroke.

 

People with angina, or who have already suffered a heart attack or stroke, are at risk of having another because of the atherosclerosis in their arteries and in this case, low dose aspirin is used to lower the risk of this.

 

This dosage of aspirin is not to be used for pain relief.

 

Published in the Daily Mail December 7 2010:

 

Taking an aspirin every day cuts the risk of dying from a range of common cancers, according to a major study. The study has led to the 100-year-old painkiller - costing just 1p a tablet - being hailed as 'the most amazing drug in the world'.

 

Experts say healthy middle-aged people who start taking low-dose aspirin around the age of 45 or 50 for 20 to 30 years could expect to reap the most benefit, because cancer rates rise with age.

 

In addition, a 75mg dose - a quarter of a standard 300mg tablet - helps prevent heart attacks and strokes even in people who have not been diagnosed with cardiovascular problems. Millions of heart patients who already take low-dose aspirin on doctors' orders to ward off a second heart attack or stroke will be getting built-in cancer protection.

 

Professor Peter Rothwell, of the John Radcliffe Hospital, Oxford, who headed the latest study of almost 26,000 patients, is convinced the ground rules have changed. He said: 'These findings provide the first proof in man that aspirin reduces deaths due to several common cancers'.

 

'Previous guidelines have rightly cautioned that in healthy middle-aged people the small risk of bleeding on aspirin partly offsets the benefits from prevention of strokes and heart attacks, but the reductions in deaths due to several common cancers will now alter this balance for many people.'

 

After five years of taking aspirin, death rates fell by 34 per cent for all cancers and 54 per cent for gastrointestinal cancers.

 

Professor Alastair Watson, of the University of East Anglia, said: 'This study provides strong evidence that taking regular aspirin for more than five years can help prevent development of a number of other forms of cancer, including lung, pancreas, oesophageal and prostate cancers'.

 

'It also indicates that the longer aspirin is taken for, the greater the benefit. It is important that people know aspirin can cause dangerous bleeding in the stomach in some patients. People wishing to take aspirin should first discuss it with their GP.'

 

Always check with your GP before taking aspirin

Customers can also buy

Other products by Aspirin

Recently Viewed

Seen a mistake on this page? Tell us about it!